Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Phase II Study of TS-142 in Patients with Insomnia
jRCT2080223515Phase 2Completed
- Sponsor
- Taisho Pharmaceutical
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Insomnia comparing TS-142 once daily with Placebo once daily (2 arms). Started Apr 2017; status: completed.
02
Drugs
vornorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on jRCT2080223515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223515.